25 results for “alpha-synuclein”. Showing 25 of 39,449.
Alpha-synuclein is a DNA binding protein that modulates DNA repair with implications for Lewy body disorders.
alpha-synuclein modulates DNA repair. First, alpha-synuclein colocalizes with
Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
alpha-synuclein. BV2 cells also preferentially phagocytosed fibrillar alpha-synuclein
Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
alpha-synuclein aggregates that are commonly known as synucleinopathies. Clinically
Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase.
Alpha-synuclein, a presynaptic protein, was found to be the major
Alpha-synuclein expression modulates microglial activation phenotype.
alpha-synuclein, and its contribution to disease mechanisms. Within neurons
Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models.
alpha-synuclein. In this study, we used a neuroblastoma-derived
Alpha-synuclein and Parkinson's disease.
alpha-synuclein in neurodegenerative diseases was first suspected after the isolation
alpha-synuclein aggregation: a link between mitochondrial defects and Parkinson's disease?
alpha-synuclein. In addition, potentially toxic effects of alpha-synuclein
GDNF reduces fibril-induced early-stage alpha-synuclein pathology after delivery of 20S proteasome inhibitor lactacystin.
alpha-synuclein are a hallmark of PD. Glial cell line
Non-coding RNAs in Parkinson's disease: Regulating SNCA and alpha-synuclein aggregation.
Alpha-synuclein proteins leading to the advancement of motor and cognitive
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
alpha-synuclein. Whether GBA1 mutations are associated with a CSF
Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
alpha-synuclein is one of the major components of LBs. Thus
Neurobiology of alpha-synuclein.
Alpha-synuclein is an abundant neuronal protein that has been
Amino acid determinants of alpha-synuclein aggregation: putting together pieces of the puzzle.
alpha-, beta- and gamma-synucleins, mouse alpha-synuclein and familial
Alpha-synuclein oligomers: a new hope.
Alpha-synuclein is a protein implicated in Parkinson's disease
Alpha-synuclein-induced neurodegeneration is exacerbated in PINK1 knockout mice.
alpha-synuclein overexpression. However, in PINK1 knockout mice, overexpression of
Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.
alpha-synuclein antibodies. Strong alpha-synuclein immunoreactivity was found in glial
Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.
alpha-synuclein double-transgenic mice survived longer than A53T alpha
Aggregation and neurotoxicity of alpha-synuclein and related peptides.
alpha-synuclein occur in several neurodegenerative diseases. Two mutant forms
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.
alpha-synuclein, neuroinflammation, and oxidative stress mediated by reactive oxygen
Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications
alpha-synuclein, neuroinflammation, and oxidative stress mediated by reactive oxygen
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
alpha-synuclein pathology, and iron homeostasis have all been implicated
[Morphochemical study of alpha-synuclein, iron and iron-containing proteins in the substantia nigra of the brain in Parkinson's disease].
alpha-synuclein, iron compounds and iron-containing proteins in the structures
Alpha-synuclein aggregation.
Alpha-synuclein is a major component of Lewy bodies in Parkinson
Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
alpha-synuclein than healthy controls. Thus, the alpha-synuclein expression